ArticleBMC cancer2023
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
Hugo Veyssiere et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it